Guideline / position statementindependent cross-checkabstract only checked I-FAST-11 standard review

IDF-DAR Ramadan guidelines 2021

Diabetes and Ramadan: Practical guidelines 2021.

Overview

Hassanein M et al.. Diabetes Res Clin Pract 2022 · PMID 35016991 · DOI 10.1016/j.diabres.2021.109185

People with diabetes who fast need individual risk assessment and medical guidance.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Management of diabetes during Ramadan fasting

How was the study done?

Practical guideline (IDF and DaR International Alliance)

How many people, animals or samples were studied?

not applicable; People with diabetes who fast

What was actually found?

Guidance on risk stratification.

How large was the observed effect?

not applicable

What do the results mean in everyday life?

Fast only with a medical plan.

What are the study's limitations?

Abstract only read

What does it say about Elawady's specific claim?

Contradicts C-FAST-03 and C-FAST-10 safety implications.

Do the results apply to Germany and Europe?

Applicable to fasting Muslims in Europe.

What can explicitly not be concluded from this study?

Specific thresholds (not in abstract).

Scientific in-depth review

1. Full reference

Authors
Hassanein M et al.
Journal
Diabetes Res Clin Pract
Year
2022
Identifier
PMID 35016991 DOI 10.1016/j.diabres.2021.109185
Verification
verified – PubMed efetch 2026-10-25 (this agent)
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract

2. Research question

Management of diabetes during Ramadan fasting

3. Study design and population

Study design
Guideline / position statement – Practical guideline (IDF and DaR International Alliance)
Population

People with diabetes who fast

Country

International (Middle East focus)

Period

2021 update

Sample size

not applicable

Inclusion and exclusion criteria

As described in the abstract; details not available in abstract.

4. Methods and endpoints

Exposure / intervention

Ramadan fasting

Comparator

not applicable

Endpoints

not applicable

Statistical methods

Expert guidance

5. Actual results

Results

Abstract: update includes fasting with type 1 diabetes, elderly, pregnancy, mental wellbeing, complications; aims to provide real-world recommendations.

Absolute risks

not reported

Authors' conclusion

People with diabetes who fast need appropriate guidance and care.

6. Strengths

  • Region-specific expertise

7. Weaknesses

  • Abstract only read

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
low
Rationale

Guideline.

9. Assessment of the statistical interpretation

not applicable

10. Relevance to the specific claim

Contradicts C-FAST-03 and C-FAST-10 safety implications.

11. Independent contrary findings

12. Transferability to Germany and Europe

Applicable to fasting Muslims in Europe.

13. Overall methodological judgement

Region-relevant guidance.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biaslow
Precision of resultsnot applicable
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

None beyond those stated.

15. Linked fact checks